Conference preview: BIO-Europe Spring convenes in Vienna


Conference preview: BIO-Europe Spring convenes in Vienna

Calin Stan /

The 13th annual BIO-Europe Spring 2019 global life science partnering event will be held March 25–27 in Vienna, Austria. Guadalupe Rodriguez and Kit Muller of EBD Group report.

EBD Group’s 13th annual BIO-Europe Spring 2019 global life science partnering event will bring together more than 2,500 executives from 1,500+ life science companies spanning an estimated 55 countries to engage in one-to-one partnering.

Partnering is now open, powered by EBD’s industry-leading platform, partneringONE. With added features this year, such as enhanced search and a responsive mobile app, partneringONE provides a golden opportunity to find and negotiate asset deals and strategic collaborations.

"EBD’s partneringONE provides a golden opportunity to find and negotiate asset deals and strategic collaborations.”

The programme includes more than 20 panels with industry experts speaking on business development and investment, therapeutic areas such as oncology, rare diseases and microbiome, cell and gene therapies, digital medicine, and a special Startup Spotlight sponsored by Lilly.

“We are very excited to be working with EBD Group to bring its springtime flagship event to Vienna,” said Eva Czernohorszky, the Vienna Business Agency’s representative at LISAvienna.

“Vienna is a great place for top-notch international events and has a diverse biotech ecosystem. We offer 360-degree support for innovative startups.”

“Austria is a life science hub due to excellent research, more than 900 life science companies and a perfect central European location. We are particularly strong in anti-infective and oncology drugs, e-health, medical imaging and industrial biotech,” added Johannes Sarx, the Austria Wirtschaftsservice’s representative at LISAvienna.  

“BIO-Europe Spring is the most significant industry event of the new year where top executives from global biotech, pharma and finance come together to access hundreds of potential partners for favourable deals toward the development of therapies and cures,” said Anna Chrisman, managing director of EBD Group and KNect365 Life Sciences.

“We’re so happy to bring the event to Vienna after two highly productive and successful BIO-Europe conferences there in the last ten years.”

BIO-Europe is a “must-attend” event for executives from the global biotechnology industry who will gain direct access to service and manufacturing partners, innovative assets, and ideas from biotech companies ranging from very early stage to large, established companies.

The event is also an important business strategy for biotech companies to meet with pharma executives and investors to propel their drug development commercialisation goals.

Register here for BIO-Europe Spring 2019.

About EBD Group

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences is the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.

Today our events—BIO-Europe, BIO-Europe Spring, BioPharm America, Biotech Showcase, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio Partnering Forum, Cell & Gene Connect, and BioEquity Europe—annually attract more than 12,000 senior life science executives who engage in over 48,000 one-to-one partnering meetings.

These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.

life science, partnering event, EBD Group, Vienna, partneringONE, mobile app, asset deals, gene therapies, rare diseases, biotechnology industry